Advances in movement disorder and stroke therapy have been rapid over the recent past and will impact the practice of clinicians dealing with patients with Parkinson's disease and other movement disorders, as well as ischemic and hemorrhagic stroke syndromes. Faculty will present an update on the most recent advances in the care of patients with movement disorders and stroke and a strategy on how to optimize the use of long-established therapies. This program complements Therapy in Neurology I: Neurological Infectious Disease and Neuro-oncology, Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease, and Therapy in Neurology III: Epilepsy and Headache, but covers independent topics.

Completion Message:

Participants should be able to describe the most recent advances in the treatment of Parkinson's disease and other movement disorders, as well as ischemic and hemorrhagic stroke syndromes, and be able to optimize the use of established treatments and integrate recent advances in treatment for patients with Parkinson's disease and other movement disorders and ischemic and hemorrhagic stroke syndromes.